TR201906539T4 - Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi. - Google Patents

Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi. Download PDF

Info

Publication number
TR201906539T4
TR201906539T4 TR2019/06539T TR201906539T TR201906539T4 TR 201906539 T4 TR201906539 T4 TR 201906539T4 TR 2019/06539 T TR2019/06539 T TR 2019/06539T TR 201906539 T TR201906539 T TR 201906539T TR 201906539 T4 TR201906539 T4 TR 201906539T4
Authority
TR
Turkey
Prior art keywords
strokes
prevention
damage caused
linalool
menthol
Prior art date
Application number
TR2019/06539T
Other languages
English (en)
Inventor
Camacho Susana
Michlig Gonzalez Stephanie
Le Coutre Johannes
Markram Henry
Pezzoli Maurizio
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of TR201906539T4 publication Critical patent/TR201906539T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Beyin travmasından ve inmelerden kaynaklanan non-inflamatuar nöron hasarının önlenmesi için bileşimler sağlanmaktadır ve bileşimler Mentol, Linalool, Icilin ve bunların kombinasyonlarından meydana gelen gruptan seçilmiş bir bileşiğin terapötik olarak etkili miktarını içermektedir. Beyin travması ve inmelerden kaynaklanan non-inflamatuar nöron hasarının tedavisi veya önlenmesi için yöntemler de sağlanmaktadır ve yöntemler bu gibi bileşimlerin uygulanmasını içermektedir.
TR2019/06539T 2013-05-24 2014-05-23 Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi. TR201906539T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361827232P 2013-05-24 2013-05-24

Publications (1)

Publication Number Publication Date
TR201906539T4 true TR201906539T4 (tr) 2019-05-21

Family

ID=50819728

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/06539T TR201906539T4 (tr) 2013-05-24 2014-05-23 Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi.

Country Status (10)

Country Link
US (2) US20160166570A1 (tr)
EP (1) EP3003292B1 (tr)
JP (2) JP2016520588A (tr)
CN (1) CN105228601A (tr)
AU (2) AU2014270341A1 (tr)
BR (1) BR112015026484A2 (tr)
CA (1) CA2908365C (tr)
ES (1) ES2721922T3 (tr)
TR (1) TR201906539T4 (tr)
WO (1) WO2014187945A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2721922T3 (es) * 2013-05-24 2019-08-06 Nestle Sa Tratamiento o prevención del daño neuronal no inflamatorio por traumatismo cerebral e ictus utilizando mentol, linalool y/o icilina
CN116018134A (zh) * 2020-03-24 2023-04-25 洪明奇 薄荷醇用于制备治疗神经退化症及中风的外用组合物的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2483635A1 (en) * 2002-04-25 2003-11-06 Alon Shalev Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
JP4742204B2 (ja) * 2005-01-21 2011-08-10 財団法人ヒューマンサイエンス振興財団 脂肪細胞分化制御剤
JP2007291069A (ja) * 2006-03-31 2007-11-08 Daiichi Sankyo Healthcare Co Ltd 抗酸化剤および／または消炎鎮痛剤組成物
GB0615136D0 (en) * 2006-07-29 2006-09-06 Univ Edinburgh Induction of analgesia in neuropathic pain
KR20090085237A (ko) * 2008-02-04 2009-08-07 김병문 천연 진주가루를 함유한 뇌질환 예방 및 치료용 한약조성물
JP6205133B2 (ja) * 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
KR20120103317A (ko) * 2011-03-10 2012-09-19 한국생명공학연구원 아실 코에이:콜레스테롤 아실트랜스퍼라제 저해활성을 갖는 고수씨 추출물 또는 이로부터 분리된 리나로올을 포함하는 조성물
SI2793883T1 (en) * 2011-12-19 2018-08-31 Dompe Farmaceutici S.P.A. Antagonists TRPM8
CN102512634A (zh) * 2011-12-26 2012-06-27 神威药业（张家口）有限公司 复方麝香软胶囊及其制备方法
CN104284668B (zh) * 2012-05-07 2018-04-20 以色列国家农业和农村发展部农业科研组织（Aro）（沃尔卡尼中心） 用于治疗神经变性疾病的天竺葵精油及其成分
ES2721922T3 (es) * 2013-05-24 2019-08-06 Nestle Sa Tratamiento o prevención del daño neuronal no inflamatorio por traumatismo cerebral e ictus utilizando mentol, linalool y/o icilina

Also Published As

Publication number Publication date
US20170189403A1 (en) 2017-07-06
JP2020011985A (ja) 2020-01-23
AU2014270341A1 (en) 2015-10-08
AU2019222781B2 (en) 2021-05-13
JP2016520588A (ja) 2016-07-14
EP3003292B1 (en) 2019-03-20
US20160166570A1 (en) 2016-06-16
CA2908365C (en) 2023-02-28
CA2908365A1 (en) 2014-11-27
BR112015026484A2 (pt) 2017-07-25
ES2721922T3 (es) 2019-08-06
US10799502B2 (en) 2020-10-13
AU2019222781A1 (en) 2019-09-12
CN105228601A (zh) 2016-01-06
WO2014187945A1 (en) 2014-11-27
EP3003292A1 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
PH12017501306A1 (en) Inhibitors of histone demethylases
MX2018000396A (es) Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4).
PH12016501750A1 (en) Human plasma kallikrein inhibitors
NZ720478A (en) Autotaxin inhibitor compounds
TW201613887A (en) Antiproliferative compounds and methods of use thereof
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
MX2016013689A (es) Compuestos 4-amino-imidazoquinolina.
EA201691354A1 (ru) Терапевтические ингибирующие соединения
EA201600204A1 (ru) Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли
EA201790576A1 (ru) Спироциклические ингибиторы катепсина с
ECSP16008797A (es) Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
EA201692020A1 (ru) Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях
EA201791432A1 (ru) Композиции на основе пролекарства монометилфумарата
BR112018002763A2 (pt) método para cicatrização de ferimentos
TR201906539T4 (tr) Mentol, Linalool ve/veya Icilin Kullanarak Beyin Travması ve İnmelerden Kaynaklanan Non-İnflamatuar Nöron Hasarının Tedavisi veya Önlenmesi.
IN2013MU03118A (tr)
BR112016016098A2 (pt) Compostos orgânicos
WO2015134603A3 (en) Methods for treating cancer
MX2018006631A (es) Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas.
EA201790020A1 (ru) Соединения, фармацевтические композиции и их применение при лечении нейродегенеративных заболеваний
BR112016028081A2 (pt) Novos compostos como agentes antituberculares
PH12020500472A1 (en) Autotaxin inhibitor compounds